Ramy Sedhom

@ramsedhom

Med Onc Fellow , interested in , PROs, & metastatic survivorship.

Baltimore, MD
Vrijeme pridruživanja: studeni 2013.

Tweetovi

Blokirali ste korisnika/cu @ramsedhom

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ramsedhom

  1. proslijedio/la je Tweet
    Poništi
  2. proslijedio/la je Tweet
    6. velj

    "The value we provide is not hanging a bag of chemo—but that is what the “buy and bill” model says our value is." Thanks to for allowing me to share thoughts on our chemo reimbursement model! 1/

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    6. velj
    Poništi
  4. proslijedio/la je Tweet
    5. velj

    I'm often asked by patients, family members, referring physicians, or clinical trial sponors: "So how do you guys pick which clinical trials to do, anyway?" There are hundreds of trials in hematologic malignancy ongoing... how to choose? Here are some thoughts. Image:

    Prikaži ovu nit
    Poništi
  5. 5. velj

    Brilliant & true! Sadly, this story extends to the medical student, resident, fellow, young faculty whose passions are offset by arbitrary metrics we set to define success Stopping the Med School 'Arms Race' via

    Poništi
  6. proslijedio/la je Tweet
    5. velj

    Billing Quality Is Medical Quality. Can create accountability for hospitals. - in ✅Itemized bill, plain language ✅Real time price transparency ✅Speak to a billing rep prn ❌Suing patients ❌Surprise bills

    Poništi
  7. 5. velj
    Poništi
  8. proslijedio/la je Tweet
    4. velj
    Poništi
  9. proslijedio/la je Tweet
    3. velj

    Feb is out! We did a formal return on investment (ROI) analysis of the IMPaCT community health worker program using randomized controlled trial evidence. Each dollar invested by Medicaid returns $2.47, annually. unroll

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    3. velj

    We made in Medscape! Thanks so much to all those who contributed their thoughts. 'How Long Do I Have?' New Online Tool for Patients With Cancer via

    Prikaži ovu nit
    Poništi
  11. 3. velj

    Reflection: was 17 years from Andy Reid’s first job as an assistant for BYU to his 1st NFL head coaching job for the Eagles Then another 21 years to his first SuperBowl win Achieving your dream takes time Enjoy the journey

    Poništi
  12. 2. velj

    thanks to for publishing our commentary, alongside many other great pieces

    Prikaži ovu nit
    Poništi
  13. 2. velj

    I worry that a similar ethical paradox exists in the US For most diseases, equal Rx yields equal outcomes among equal patients. Yet, we know this does NOT happen & there is not enough concern about this Disparities always increase when there is scientific progress in medicine

    Prikaži ovu nit
    Poništi
  14. 2. velj

    We conclude that screening in LICs without good follow-up care across the cancer continuum makes little clinical or ethical sense; resources are better spent on education related to tobacco cessation, alcohol control, diet and lifestyle promotion

    Prikaži ovu nit
    Poništi
  15. 2. velj

    screening must be acceptable, equitable, accessible, sustainable and economically efficient (one can see here how the aims for screening are different in LIC & HICs) for screening programs to be effective & appropriate -- affordable, high quality treatment must be available

    Prikaži ovu nit
    Poništi
  16. 2. velj

    quick side note that many QI projects (here in the US) have a similar dilemma (SAD!) I've led a project with the goal of ↑retinopathy screening for diabetics in a FQHC & quickly realized we had no specialist to send the patients to! EQUITY is a global problem!

    Prikaži ovu nit
    Poništi
  17. 2. velj

    resources for cancer are limited in low-income relative to HIC and thus mortality rates are greater screening in LIC has a paradoxical dilemma: -no screening = ↑ odds of adv dz (harder to Rx) -screening prog = what do u do w/+ tests if no avail Rx (+anxiety/financial tox)

    Prikaži ovu nit
    Poništi
  18. 2. velj

    Thx for the invitation & mentorship on this piece. We discuss the ethics of screening a woman for breast cancer in a remote, resource-laden region, without access to treatment (this is key) A few broad lessons learned & themes that may apply to western medicine

    Prikaži ovu nit
    Poništi
  19. proslijedio/la je Tweet
    2. velj

    Great thread highlighting new work from and his mentees and

    Poništi
  20. proslijedio/la je Tweet
    2. velj

    I’m super excited about the 3 papers we published in last two days, because in all these three papers I had the opportunity to work with a younger colleague who is going to be a KOL in oncology. 1. 2. 3.

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·